Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7118 results

Novo Nordisk posts strong results, reassures with guidance

Novo Nordisk posts strong results, reassures with guidance

30-10-2014

Global diabetes care giant, Denmark’s Novo Nordisk saw its shares gain 4% to 265.80 Danish kroner this…

DiabetesFinancialNovo NordiskPharmaceutical

Russian Parliament to restrict imports of unregistered drugs

30-10-2014

The Russian National Parliament (State Duma) plans to impose a ban on the imports of unregistered drugs…

PharmaceuticalPoliticsRegulationRussia

US lawmakers introduce Bill to speed Ebola treatments development

30-10-2014

Two US Senators have announced their intention to introduce a bill to speed the development of treatments…

Anti-viralsLegalPharmaceuticalResearchTropical diseasesUSAVaccines

Orphan drug market forecast to reach $176 billion by 2020

30-10-2014

In 2020, orphan drugs are expected to account for 19% of the total share of prescription drug sales excluding…

Markets & MarketingPharmaceuticalRare diseases

NicOx's acquisitions pay off as sales rocket to 4 million euros in third quarter

NicOx's acquisitions pay off as sales rocket to 4 million euros in third quarter

30-10-2014

French pharma company NicOx has achieved sales of 4 million euros ($5 million) in the third quarter of…

FinancialFranceNicOxOphthalmicsPharmaceutical

Helsinn's anamorelin improves lean body mass in anorexia-cachexia according to Phase III data

Helsinn's anamorelin improves lean body mass in anorexia-cachexia according to Phase III data

30-10-2014

Swiss cancer specialist Helsinn has reported positive results from a Phase III study in anamorelin in…

anamorelinHelsinnOncologyPharmaceuticalResearchSwitzerland

AstraZeneca partners with Manchester University on improving drug delivery and efficacy

AstraZeneca partners with Manchester University on improving drug delivery and efficacy

30-10-2014

Anglo-Swedish drug major AstraZeneca has entered into a strategic collaboration with the University of…

AstraZenecaHealth Medical PharmaPharmaceuticalResearchUK

US FDA approves first vaccine to prevent serogroup B meningococcal disease

30-10-2014

The US Food and Drug Administration yesterday granted accelerated approval for pharma major Pfizer’s…

PfizerPharmaceuticalRegulationTrumenbaUSAVaccines

Bayer sees strong third-qtr sales and earnings growth

Bayer sees strong third-qtr sales and earnings growth

30-10-2014

Reporting third-quarter 2014 financials this morning, German pharma major Bayer (BAYN: DE) said group…

BayerFinancialPharmaceutical

EMA advises GlaxoSmithKline on Ebola vaccine development

29-10-2014

The European Medicines Agency has given scientific advice to UK pharma major GlaxoSmithKline on its development…

Anti-viralsGlaxoSmithKlinePharmaceuticalRegulationResearchVaccines

Leo Pharma reports positive results in its trial of Daivobet in psoriasis

Leo Pharma reports positive results in its trial of Daivobet in psoriasis

29-10-2014

Independent Danish dermatology specialist Leo Pharma has demonstrated significant improvement in psoriasis…

DaivobetDenmarkDermatologicalsLEO PharmaPharmaceuticalResearch

UCB calls upon UK government for greater incentives for industry partnering

UCB calls upon UK government for greater incentives for industry partnering

29-10-2014

Belgian drugmaker UCB has called for further collaboration in life sciences to enhance drug discovery…

PharmaceuticalResearchUCBUKUnited Kingdom

Receptos rockets on positive mid-stage results for UC drug candidate

29-10-2014

US discovery and development company Receptos saw its shares rocket 47% to a new high, after it announced…

Gastro-intestinalsNeurologicalPharmaceuticalReceptosResearchRPC1063

Specialty care and Somatuline drive Ipsen's positive third quarter financials

Specialty care and Somatuline drive Ipsen's positive third quarter financials

29-10-2014

French drugmaker Ipsen has reported sales of 329 million euros ($419.1 million) for the third quarter…

DysportFinancialFranceIpsenPharmaceuticalSomatuline

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

29-10-2014

Netherlands-based company Qiagen has announced a master collaboration agreement with Japanese drug major…

Astellas PharmaJapanLicensingNetherlandsOncologyPharmaceuticalQiagen

PBS means Australian patients and government are paying less for products

PBS means Australian patients and government are paying less for products

29-10-2014

Australian patients continue to pay less for medicines due to a notable rise in the number of prescriptions…

AustraliaPharmaceuticalPharmaceutical sciencesPharmacologyRegulation

Sanofi ousts CEO Viehbacher, despite recent denials

Sanofi ousts CEO Viehbacher, despite recent denials

29-10-2014

Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion,…

BoardroomFranceManagementPharmaceuticalSanofi

Pfizer beats sales and earnings forecast for the third quarter

Pfizer beats sales and earnings forecast for the third quarter

28-10-2014

US pharma giant Pfizer has beaten the forecasts for both its sales and its earnings for the third quarter…

FinancialLyricaPfizerPharmaceuticalUSAViagra

Recordati reports strong earnings growth for first nine months of 2014

28-10-2014

Italian pharma company Recordati has reported a strong set of financials for the first three-quarters…

FinancialPharmaceuticalRecordati

Russian approval for Norgine/Takeda’s MoviPrep

28-10-2014

Netherlands-headquartered independent drugmaker Norgine says that its partner, Japan’s largest pharma…

Gastro-intestinalsMoviPrepNorginePharmaceuticalRegulationRussiaTakeda Pharmaceutical

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

28-10-2014

Rare and infectious disease specialist Sarepta provided an update on its discussions with the US Food…

CNS DiseaseseteplirsenPharmaceuticalRegulationSarepta TherapeuticsUSA

Bristol-Myers Squibb signs deal with Korean company OliPass

Bristol-Myers Squibb signs deal with Korean company OliPass

28-10-2014

Privately-held Korean biopharmaceutical company OliPass has announced a worldwide strategic alliance…

Bristol-Myers SquibbOliPassPharmaceuticalResearchRest of the World

1 to 25 of 7118 results

Parexel

Parexel

Back to top